Biotechnology Market Size, Share, Growth Analysis, By Type (Red biotechnology, green biotechnology), By Technology (Nano Biotechnology, PCR Technology), By Application (Medical Biotechnology, Agricultural Biotechnology), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations), By Region - Industry Forecast 2026-2033

Global Biotechnology Market size was valued at USD 2171.48 Billion in 2024 and is poised to grow from USD 2,163.5 billion in 2024 to USD 6,644.2 billion by 2032, growing at a CAGR of USD 2496.33 Billion in 2025 during the forecast period USD 7615.12 Billion by 2033.

Key vendors in the Biotechnology Market include Amgen Inc., Gilead Sciences Inc., Biogen Inc., Regeneron Pharmaceuticals Inc., Moderna Inc., Genentech Inc., Novozymes A/S, CSL Limited, Samsung Biologics Co. Ltd., and Lonza Group AG. These companies focus on biopharmaceutical development, gene and cell therapies, vaccine innovation, contract manufacturing services, and advanced biotechnology research to address healthcare, industrial, and agricultural applications globally.

The key driver of the Biotechnology Market is the increasing demand for innovative therapies and advanced healthcare solutions. Rising prevalence of chronic diseases, growing investments in biopharmaceutical research and development, and advancements in genetic engineering, cell therapy, and personalized medicine are significantly driving market growth globally.

The key market trend in the Biotechnology Market is the growing adoption of gene editing, cell and gene therapies, and personalized medicine. Advances in technologies such as CRISPR, mRNA platforms, and synthetic biology are enabling the development of targeted treatments, while increasing investment in biopharmaceutical innovation and precision healthcare continues to shape market growth globally.

North America accounted for the largest share in the Biotechnology Market due to strong investments in research and development, the presence of leading biotechnology and biopharmaceutical companies, and a well-established healthcare infrastructure. Increasing adoption of advanced therapies, favorable regulatory support, and growing demand for personalized medicine further support regional market dominance.